ENDO PHARM Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENDO PHARM, and when can generic versions of ENDO PHARM drugs launch?
ENDO PHARM has ten approved drugs.
There are five US patents protecting ENDO PHARM drugs.
There are one hundred and sixty-nine patent family members on ENDO PHARM drugs in thirty-two countries.
Summary for ENDO PHARM
| International Patents: | 169 |
| US Patents: | 5 |
| Tradenames: | 7 |
| Ingredients: | 5 |
| NDAs: | 10 |
| Patent Litigation for ENDO PHARM: | See patent lawsuits for ENDO PHARM |
| PTAB Cases with ENDO PHARM as petitioner: | See PTAB cases with ENDO PHARM as petitioner |
| PTAB Cases with ENDO PHARM as patent owner: | See PTAB cases with ENDO PHARM as patent owner |
Drugs and US Patents for ENDO PHARM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | DISCN | Yes | No | 8,114,383 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-001 | Dec 9, 2011 | DISCN | Yes | No | 7,851,482 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | DELATESTRYL | testosterone enanthate | INJECTABLE;INJECTION | 009165-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | 8,871,779 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | 8,192,722 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | DISCN | Yes | No | 8,114,383 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENDO PHARM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-003 | Dec 9, 2011 | 8,075,872 | ⤷ Sign Up |
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-006 | Dec 9, 2011 | 8,075,872 | ⤷ Sign Up |
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-006 | Dec 9, 2011 | 8,309,122 | ⤷ Sign Up |
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-007 | Dec 9, 2011 | 8,309,060 | ⤷ Sign Up |
| Endo Pharms | OPANA ER | oxymorphone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 201655-005 | Dec 9, 2011 | 8,329,216 | ⤷ Sign Up |
| Endo Pharms | MOBAN | molindone hydrochloride | CONCENTRATE;ORAL | 017938-001 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ENDO PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Tablets | 7.5 mg and 15 mg | ➤ Subscribe | 2008-05-29 |
| ➤ Subscribe | Extended-release Tablets | 5 mg, 10 mg, 20 mg and 40 mg | ➤ Subscribe | 2007-11-23 |
| ➤ Subscribe | Extended-release Tablets | 30 mg | ➤ Subscribe | 2008-06-12 |
International Patents for ENDO PHARM Drugs
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
